Advancing Novel Surrogate Endpoints For Rare Disease Drug Development Workshop
Virtual Event
Advancing treatments for rare diseases requires innovative ways to measure success. Join FDA, researchers, clinicians, and innovators for a free, one-day virtual workshop open to the public focused on emerging scientific and regulatory pathways for advancing surrogate endpoints in rare disease drug development. This workshop is being convened in support of the Rare Disease Endpoint … Read more